Process patent-related disputes seen intensifying

With Korean pharmaceutical firms vigorously aiming to launch the first generic versions of major original drugs whose patent is to be soon expired, a number of patent disputes among domestic pharmaceutical firms and foreign counterparts would likely be intensifying, market sources said recently.

1) Risperidone (Risperidal)

Janssen Korea filed a lawsuit against Whanin Pharm which has marke...